Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Articles

Some states look to block access to approved drugs. 

FDA Drug Regulation Challenged by Anti-Abortion Campaign

VeriSIM Life and Mayo Clinic are collaborating to develop new promising drug candidates.

VeriSIM Life and Mayo Clinic Team Up to Co-develop New Therapies

NRG Therapeutics and Domainex aim to develop novel small-molecule drugs to treat neurodegenerative disorders, such as Parkinson’s disease.

NRG Therapeutics and Domainex Partner on Parkinson’s Disease Drug Development Project

LG Chem has decided to proceed with IND-enabling studies and has renewed a license with Avacta.

LG Chem Renews License with Avacta for IND Studies

Tanya Landon is a partner, Global Arbitration, Trade and Advocacy at Sidley Austin—an international law firm.

Dorothee Schramm is a partner, Global Arbitration, Trade and Advocacy at Sidley Austin—an international law firm.

As a result of the disruptions caused by the COVID-19 pandemic, global arbitration has adapted to a ‘new normal’.

Trends in International Arbitration: The Fallout from COVID-19

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

As we reach further afield in the molecular universe, we encounter new types of problems to resolve.

Process Development Struggles with Molecular Diversity

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Dame Deborah James’ legacy and the millions raised through her campaigning will undoubtedly be a big boost to clinical research, ultimately providing new and promising treatments for bowel cancer patients. 

Bottoms Up! Research into Bowel Cancer Therapies Gain Funding Boost

Mike Hennessy Jr. is the Chairman and CEO of 

Systemic inefficiencies in the pharmaceutical industry undermine problem-solving efforts.

How Can We Come Up Short So Often?

Getinge’s new DPTE-EXO with Sleeveless DPTE-BetaBag is an alpha port with an external opening and an integrated funnel for automated aseptic transfer.

Getinge Launches New DPTE-EXO with Sleeveless DPTE-BetaBag for Aseptic Transfer

Following the recommendation of an independent vaccine panel, FDA is advising vaccine manufacturers to include an Omicron BA.4 and BA.5 component to their booster doses.

News